Since climate change and global warming are wreaking havoc, exposure to climate risk insights is vital because it helps in the right course of action. As a result, Informatica Intelligent Data ...

BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in ...

The IDMC conducted an in-depth evaluation of interim safety data from 89 enrolled patients and found no significant safety concerns that would impact the trial's continuation. To date, Daewoong has ...

OlympiA Phase III trial of Lynparza in the adjuvant treatment of BRCA-mutated high-risk HER2-negative early breast cancer will be analysed and reported early The OlympiA Phase III trial for ...

PharmaMar (MSE:PHM) has announced today that the Independent Data Monitoring Committee (IDMC) has notified the Company of its recommendation that the Phase III (ATLANTIS) trial currently under way ...

(RTTNews) - SELLAS Life Sciences Group, Inc. (SLS), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, Thursday ...

Ideaya Biosciences (IDYA) announced the Independent Data Monitoring Committee, or IDMC, recommendation of a move-forward dose and the completion of the Part 2a dose optimization consistent with the ...

(King of Prussia, PA; September 19, 2012) – Theorem Clinical Research Inc., a full-service contract research organization (CRO) that provides core clinical research and development services, continues ...

Third Independent Data Monitoring Committee (IDMC) review confirms safety and continuation of the study 94 patients enrolled out of 102 planned across Korea and the U.S. Interim baseline ...